Navigation Links
A 'clear' choice for clearing 3-D cell cultures
Date:9/3/2014

PROVIDENCE, R.I. [Brown University] Because Brown University biomedical engineering graduate student Molly Boutin needed to study how neural tissues grow from stem cells, she wanted to grow not just a cell culture, but a sphere-shaped one. Cells grow and interact more naturally in 3-D cultures than when they're confined to thin slides or dishes.

But the very advantage of a culture having thickness also poses a challenge: How to see all the cells and their connections all the way through the culture. It's a problem that confronts many biologists, physicians, bioengineers, drug developers- and others who also see 3-D cultures as a useful stage before moving to animal models.

"As I was imaging these tissues I was only able to get the outer layer or two of cells and that wasn't a very good representation of what was going on inside of the sphere," Boutin said.

There are inelegant ways to slice up an engineered 3-D tissue for imaging and then to reconstruct it, but a more tantalizing solution seemed likely to come from one of the chemical treatments invented in just the last few years to make tissues see-through. But which one, if any, would work with her scaffold-free engineered neural tissues? To find out, Boutin and adviser, Diane Hoffman-Kim, associate professor of medical science in the Department of Molecular Pharmacology, Physiology, and Biotechnology, decided to test the three simplest methods: ClearT2, SeeDB and Scale.

Their results which read like a Consumer Reports article for the lab bench set now appear online in the journal Tissue Engineering Part C: Methods.

For Boutin's critieria, the ClearT2 method turned out to be clear winner. For her little balls of neural tissue 100 millionths of a meter in diameter ClearT2 allowed her to see fluorescing cells at all depths of focus and, importantly, it did not change the size of the tissue. Scale made her "neural spheres" substantially larger, while SeeDB made them smaller and didn't improve clarity as much.

Maintaining the tissue culture size is important because Boutin wants to know the physical dimensions of growth in the culture, such as the axons that one neuron might extend to another.

While ClearT2 worked within 1.5 hours, Scale and SeeDB took three days, Boutin said.

She ran several further tests with ClearT2, including with other types of healthy and cancerous neural cells, and ClearT2 continued to perform well, even allowing her to image extracellular matrix.

In the paper Boutin and Hoffman-Kim acknowledge that the results with different methods may vary with different samples, but they expect that for many "scaffold-free" engineered 3-D neural tissues tissues that grow without added matrix supports ClearT2 should work well.

Knowing that could clear the way for many research projects with 3-D tissues.


'/>"/>

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Source:Eurekalert

Related biology news :

1. IU biologists offer clearer picture of how protein machine systems tweak gene expression
2. New paper by Notre Dame researchers describes method for cleaning up nuclear waste
3. Report presents designs for study of cancer risks near US nuclear facilities
4. Dartmouth scientists track radioactive iodine from Japan nuclear reactor meltdown
5. Postpone the nuclear waste decision
6. Autologous bone marrow-derived mononuclear cell transplants can reduce diabetic amputations
7. Scientists core into Californias Clear Lake to explore past climate change
8. Researchers at GW receive federal funds to study the effect earthquakes have on nuclear reactors
9. Where to put nuclear waste?
10. Structure of RNAi complex now crystal clear
11. Europe clears the air
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... , November 29, 2016 Nearly one billion ... Continue Reading ... ... part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The ...
(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... I/II dose escalation and expansion clinical trial for its lead drug candidate, AC0010, ... purpose of the trial was to determine the safety, antitumor activity, and recommended ...
(Date:12/7/2016)... , Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dr. Dan Kephart as its chief science ... will assume his responsibilities at Neogen effective Jan. 1. ... director for the agribusiness unit of Thermo Fisher Scientific, ... at Life Technologies. His extensive industry experience also includes ...
Breaking Biology Technology: